Paper626490
Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycoside.
Waitz JA and 3 others. Antimicrob Agents Chemother, 1978. Cited by 25 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycoside. Papers, record 626490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/626490
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycoside.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gentamicins | Major topic |
| Sisomicin | Major topic |
| Animals | |
| Cats | |
| Dogs | |
| In Vitro Techniques | |
| Isomerism | |
| Male | |
| Mice | |
| Microbial Sensitivity Tests | |
| Rats |
Source PubMed
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 879,737 | Renal pharmacology of netilmicin. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/879737 | PubMed |
| 2 | 1,008,541 | Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/1008541 | PubMed |
| 3 | 4,468,277 | Mutamicins; biosynthetically created new sisomicin analogues. | J Antibiot (Tokyo) | 1974 | https://conductscience.org/library/papers/4468277 | PubMed |
| 4 | 4,692,995 | Kinetics of cephaloridine in experimental wounds. | Am J Med Sci | 1973 | https://conductscience.org/library/papers/4692995 | PubMed |
| 5 | 4,694,402 | Concentration of antibacterial agents in interstitial tissue fluid. | Br Med J | 1973 | https://conductscience.org/library/papers/4694402 | PubMed |
| 6 | 4,992,170 | Antibiotic 6640. 3. Biological studies with antibiotic 6640, a new broad-spectrum aminoglycoside antibiotic. | J Antibiot (Tokyo) | 1970 | https://conductscience.org/library/papers/4992170 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 20,805,391 | Synthesis and spectrum of the neoglycoside ACHN-490. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20805391 | PubMed |
| 6,967,296 | 5-epi-Sisomicin and 5-epi-Gentamicin B: substrates for aminoglycoside-modifying enzymes that retain activity against aminoglycoside-resistant bacteria. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6967296 | PubMed |
| 6,376,062 | Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use. | Drugs | 1984 | https://conductscience.org/library/papers/6376062 | PubMed |
| 3,914,858 | Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/3914858 | PubMed |
| 3,518,623 | Aminoglycoside research 1975-1985: prospects for development of improved agents. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3518623 | PubMed |
| 742,870 | Comparison of 5-episisomicin (Sch 22591), gentamicin, sisomicin, and tobramycin in treatment of experimental Pseudomonas infections in mice. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/742870 | PubMed |
| 697,347 | Activity of 5-episisomicin compared with that of other aminoglycosides. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/697347 | PubMed |
| 697,346 | In vitro studies with Sch 21420 and Sch 22591: activity in comparison with six other aminoglycosides and synergy with penicillin against enterococci. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/697346 | PubMed |
| 101,131 | In vitro activity of 5-episisomicin in bacteria resistant to other aminoglycoside antibiotics. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/101131 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/626490
GET https://conductscience.org/api/papers/v1/626490/authors